Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
More about Open Access at the CrickAuthors list
Filipe Correia Martins Dominique-Laurent Couturier Ines de Santiago Carolin Margarethe Sauer Maria Vias Mihaela Angelova Deborah Sanders Anna Piskorz James Hall Karen Hosking Anumithra Amirthanayagam Sabina Cosulich Larissa Carnevalli Barry Davies Tom Watkins Ionut G Funingana Helen Bolton Krishnayan Haldar John Latimer Peter Baldwin Robin Crawford Matthew Eldridge Bristi Basu Mercedes Jimenez-Linan Andrew W Mcpherson Nicholas McGranahan Kevin Litchfield Sohrab P Shah Iain McNeish Carlos Caldas Gerard Evan Charles Swanton James D Brenton Toggle all authors (33)
Abstract
Chromosomal instability is a major challenge to patient stratification and targeted drug development for high-grade serous ovarian carcinoma (HGSOC). Here we show that somatic copy number alterations (SCNAs) in frequently amplified HGSOC cancer genes significantly correlate with gene expression and methylation status. We identify five prevalent clonal driver SCNAs (chromosomal amplifications encompassing MYC, PIK3CA, CCNE1, KRAS and TERT) from multi-regional HGSOC data and reason that their strong selection should prioritise them as key biomarkers for targeted therapies. We use primary HGSOC spheroid models to test interactions between in vitro targeted therapy and SCNAs. MYC chromosomal copy number is associated with in-vitro and clinical response to paclitaxel and in-vitro response to mTORC1/2 inhibition. Activation of the mTOR survival pathway in the context of MYC-amplified HGSOC is statistically associated with increased prevalence of SCNAs in genes from the PI3K pathway. Co-occurrence of amplifications in MYC and genes from the PI3K pathway is independently observed in squamous lung cancer and triple negative breast cancer. In this work, we show that identifying co-occurrence of clonal driver SCNA genes could be used to tailor therapeutics for precision medicine.
Journal details
Journal Nature Communications
Volume 13
Issue number 1
Pages 6360
Available online
Publication date
Full text links
Publisher website (DOI) 10.1038/s41467-022-33870-0
Europe PubMed Central 36289203
Pubmed 36289203